Abstract:Abstract Background Increasing evidence showed that carbamylated lipoprotein accelerated atherosclerosis. However, whether such modification of high-density lipoprotein (HDL) particles alters in type 2 diabetes mellitus (T2DM) patients and facilitates vascular complications remains unclear. We aimed to investigate the alteration of the carbamylation in HDL among T2DM patients and clarify its potential role in atherogenesis. Methods A total of 148 consecutive T2DM patients undergoning angiography and 40 age- and gender-matched control subjects were included. HDL was isolated from plasma samples, and the concentration of HDL carbamyl-lysine (HDL-CBL) was measured. Furthermore, the HDL from subjects and in-vitro carbamylated HDL (C-HDL) was incubated with endothelial cells and monocyte to endothelial cell adhesion. Adhesion molecule expression and signaling pathway were detected. Results Compared with the control group, the HDL-CBL level was remarkably increased in T2DM patients (6.13 ± 1.94 vs 12.00 ± 4.06 (ng/mg), P < 0.001). Of note, HDL-CBL demonstrated a more significant increase in T2DM patients with coronary artery disease (CAD) (n = 102) than those without CAD (n = 46) (12.75 ± 3.82 vs. 10.35 ± 4.11(ng/mg), P = 0.001). Multivariate logistic regression analysis demonstrated that higher HDL-CBL level was independently associated with a higher prevalence of CAD in diabetic patients after adjusting for established cofounders (adjusted odds ratio 1.174, 95% confidence Interval 1.045–1.319, p = 0.017). HDL from diabetic patients with CAD enhanced greater monocyte adhesion than that from the non-CAD or the control group ( P < 0.001). Such pro-atherogenic capacity of diabetic HDL positively correlated with HDL-CBL level. Furthermore, in-vitro incubation of carbamylated HDL (C-HDL) with endothelial promoted monocyte to endothelial cell adhesion, induced upregulation of cell adhesion molecules expression, and activated NF-κB/p65 signaling in endothelial cells. Inhibiting carbamylation of HDL or NF-κB activation attenuated the monocyte to endothelial cell adhesion and cell surface adhesion molecules expression. Conclusions Our study identified elevated carbamylation modification of HDL from T2DM patients, especially in those with concomitant CAD. We also evidenced that C-HDL enhanced monocyte to endothelial cell adhesion, indicating a potential pro-atherogenic role of C-HDL in atherosclerosis among T2DM patients. Trial registration https://register.clinicaltrials.gov , NCT04390711 Registered on 14 May 2020; Retrospectively registered

Diabetes-Invoked High-Density Lipoprotein and Its Association with Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.

Changes of Th1/Th2 Cell Ratio in the Peripheral Blood of Patients with Both Coronary Heart Disease and Diabetes

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion

HDL-C/apoA-I Ratio is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome.

Low Density Lipoprotein Cholesterol Level Inversely Correlated with Coronary Flow Velocity Reserve in Patients with Type 2 Diabetes.

Relationship between serum lipoprotein (a) level and risk and severity of coronary atherosclerotic heart disease in patients with type 2 diabetes mellitus

Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus.

THE CORONARY ANGIOGRAPHY FEATURES AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CORONARY HEART DISEASE COMPLICATED TYPE 2 DIABETES MELLITUS

The Value of Small Dense Low-Density Lipoprotein Cholesterol in Predicting the Risk and Severity of Coronary Heart Disease in Patients with Type 2 Diabetes Mellitus

Characteristics of HDL2b Changes and Their Significance in Prediction of Risks for Coronary Artery Disease in Type 2 Diabetic Patients

Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus

High-density Lipoprotein of Patients with Type 2 Diabetes Mellitus Upregulates Cyclooxgenase-2 Expression and Prostacyclin I-2 Release in Endothelial Cells: Relationship with HDL-associated Sphingosine-1-phosphate

Different Associations Between High Density Lipoprotein Cholesterol and Cardiovascular Diseases in Diabetic and Non-diabetic People: A Prospective Community-based Study

Correlationship Between High Sensitive C -Reactive Protein and Interleukin -6 in Patients with Type 2 Diabetes Mellitus Complicated with Coronary Artery Disease

Serum Amyloid A Enrichment Impairs the Anti-Inflammatory Ability of HDL from Diabetic Nephropathy Patients.

Coronary inflammation based on pericoronary adipose tissue attenuation in type 2 diabetic mellitus: effect of diabetes management

Correlation of Low Density Lipoprotein Cholesterol with Coronary Flow Reserve in Patients with Type 2 Diabetes

Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.

Nonenzymatic Glycation of High‐density Lipoprotein Impairs Its Anti‐inflammatory Effects in Innate Immunity